About BPC 5mg + TB 5mg
This two-component blend combines BPC-157 and TB-500 in equal milligram amounts, offering a ready-to-use format for laboratories studying tissue repair across complementary endpoints. BPC-157 is investigated for its effects on angiogenesis, mucosal integrity, and connective-tissue healing, while TB-500, the thymosin beta-4 fragment, is studied for actin-cytoskeleton regulation, cell migration, and wound-closure behavior. Used together, the pair is of interest for protocols that track both vascular remodeling and cellular motility within the same experimental model. Formulation quality is the main technical challenge: the two peptides differ in solubility and hygroscopicity, and co-lyophilization must preserve accurate ratios without aggregation or moisture-driven degradation. Shandong Shengyuan manufactures this blend from individually qualified components, confirms both molecular species by LC-MS, and releases lots at 99.3% combined RP-HPLC purity or higher with batch-specific documentation. Supplied lyophilized for research use only; not for human or veterinary use.
Research Applications
- Wound-healing research
- Cytoskeleton and motility studies
- Vascular regeneration models
- Tissue recovery protocols
- Peptide combination studies
Quality & Documentation
Every batch of BPC 5mg + TB 5mg is manufactured under our documented quality system and released with a Certificate of Analysis covering HPLC purity, mass spectrometry identity, peptide content, water content, and endotoxin. The batch code on your vial can be verified online in the COA lookup section of this site.
TB-500 
KPV 
BPC157